EUVIMEDEUVIMED entdecken
Crossref

Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution

Riccardo Leni, Marco Roscigno iD, Paolo Barzaghi, Giovanni La Croce, Michele Catellani, Antonino Saccà, Mario de Angelis, Francesco Montorsi iD, Alberto Briganti, Luigi Filippo Da Pozzo

BJU International · 2024

DOI: 10.1111/bju.16259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Riccardo Leni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology, Department of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Watchful Waiting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To report oncological outcomes of active surveillance (AS) at a single non‐academic institution adopting the standardised Prostate Cancer Research International Active Surveillance (PRIAS) protocol. Patients and Methods Competing risk analyses estimated the incidence of overall mortality, metastases, conversion to treatment, and grade reclassification. The incidence of reclassification and adverse pathological findings at radical prostatectomy were compared between patients fulfilling all PRIAS inclusion criteria vs those not fulfilling at least one.

Results

We analysed 341 men with Grade Group 1 prostate cancer (PCa) followed on AS between 2010 and 2022. There were no PCa deaths, two patients developed distant metastases and were alive at the end of the study period. The 10‐year cumulative incidence of metastases was 1.9% (95% confidence interval [CI] 0.33–6.4%). A total of 111 men were reclassified, and 127 underwent definitive treatment. Men not fulfilling at least one PRIAS inclusion criteria ( n = 43) had a higher incidence of reclassification (subdistribution hazards ratio 1.73, 95% CI 1.07–2.81; P = 0.03), but similar rates of adverse pathological findings at radical prostatectomy.

Conclusion

Metastases in men on AS at a non‐academic institution are as rare as those reported in established international cohorts. Men followed without stringent inclusion criteria should be counselled about the higher incidence of reclassification and reassured they can expect rates of adverse pathological findings comparable to those fulfilling all criteria. Therefore, AS should be proposed to all men with low‐grade PCa regardless of whether they are followed at academic institutions or smaller community hospitals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsWatchful WaitingHumansMaleMiddle AgedAgedFollow-Up StudiesProstatectomyNeoplasm GradingNeoplasm Metastasis

Stichwörter der Autor:innen

active surveillancefollow‐upmetastasesprostate cancerreclassification

Autor:innen und Institutionen

  • Division of Experimental Oncology, Department of Urology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • University of Milano-Bicocca, Milan, Italy.
  • Department of Urology, ASST Papa Giovanni XXIII, Bergamo, Italy.

ORCID-Profile: Marco Roscigno, Francesco Montorsi

Zitieren

APA

Leni, R., Roscigno, M., Barzaghi, P., La Croce, G., Catellani, M., Saccà, A., de Angelis, M., Montorsi, F., Briganti, A., & Da Pozzo, L. F. (2024). Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution. BJU International. https://doi.org/10.1111/bju.16259

Vancouver

Leni R, Roscigno M, Barzaghi P, La Croce G, Catellani M, Saccà A, et al. Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution. BJU International. 2024. doi:10.1111/bju.16259

BibTeX
@article{Leni2024,
  author = {Leni, Riccardo and Roscigno, Marco and Barzaghi, Paolo and La Croce, Giovanni and Catellani, Michele and Saccà, Antonino and de Angelis, Mario and Montorsi, Francesco and Briganti, Alberto and Da Pozzo, Luigi Filippo},
  title = {Medium‐term follow up of active surveillance for early prostate cancer at a non‐academic institution},
  journal = {BJU International},
  year = {2024},
  doi = {10.1111/bju.16259}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche